Citations

Clear

6273 citation(s) found for "To, Andrew".

The Selinexor in Advanced Liposarcoma (SEAL) study: A phase 2/3, multicenter, randomized, double blind study of selinexor versus placebo in patients with advanced, unresectable, dedifferentiated liposarcoma (DDLS).
Gounder, Mrinal M. , Wagner, Andrew J. , Somaiah, Neeta , Riedel, Richard F. , Attia, Steven , Razak, Albiruni R. Abdul, Cranmer, Lee D. , Okuno, Scott H. , Choe-Juliak, Cassandra, Shacham, Sharon, Kauffman, Michael , Chawla, Sant P. , Riedel, Richard F , Schwartz, Gary K. , Milhem, Mohammed

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS11072-TPS11072

10.1200/jco.2016.34.15_suppl.tps11072 Get It

Safety and efficacy of PD-1 blockade using pembrolizumab in patients with advanced soft tissue (STS) and bone sarcomas (BS): Results of SARC028—A multicenter phase II study.
Tawbi, Hussein, Crowley, John, Tine, Brian Andrew Van, Hu, James , Schuetze, Scott M. , Attia, Steven , Priebat, Dennis A., Okuno, Scott H. , Riedel, Richard F. , Movva, Sujana , Baker, Laurence H. , Maki, Robert G. , Patel, Shreyaskumar , Investigators, for SARC028, Maki, Robert G , Riedel, Richard F , Burgess, Melissa , D'Angelo, Sandra P , Davis, Lara E. , Reed, Damon R. , Reinke, Denise K. , Investigators, for SARC028

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 11006-11006

10.1200/jco.2016.34.15_suppl.11006 Get It

NK/T cell lymphoma in the U.S: A population-based study using the National Cancer Database from 1998-2012.
Karkera, Amritha C., Borgert, Andrew J. , Parsons, Benjamin M. , Go, Ronald S.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e19038-e19038

10.1200/jco.2016.34.15_suppl.e19038 Get It

Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.
Chanan‐Khan, Asher , Agarwal, Amit , Kumar, Shaji , Diehl, Susan, Cordero, Jaclyn, Munasinghe, Wijith, Zhu, Ming , Maciag, Paulo , Verdugo, Maria E., Moreau, Philippe , Roberts, Andrew W. , Facon, Thierry T.F. , Touzeau, Cyrille , Ross, Jeremy A. , Salem, Ahmed Hamed , Leverson, Joel D. , Harrison, Simon J

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8011-8011

10.1200/jco.2016.34.15_suppl.8011 Get It

Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): 60 week follow-up of the phase III PERSIST-1 trial.
Egyed, Miklós , Szőke, Anita , Suvorov, Aleksandr , Perkins, Andrew C. , Mayer, Jiřı́ , Schouten, Harry C. , Tosi, Patrizia , Granston, Tanya, Nangalia, Jyoti , Harrison, Claire , Mesa, Ruben A. , Ganly, Peter S. , Farber, Charles Michael , Zachée, Pierre , Scheid, Christof , Dean, James P. , Kiladjian, Jean‐Jacques , Vannucchi, Alessandro M. , Mead, Adam J. , Perkins, Andrew C

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7065-7065

10.1200/jco.2016.34.15_suppl.7065 Get It

Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): Outcomes in patients (pts) with baseline (BL) thrombocytopenia.
Harrison, Claire , Egyed, Miklós , Szőke, Anita , Suvorov, Aleksandr , Perkins, Andrew C. , Mayer, Jiřı́ , Schouten, Harry C. , Tosi, Patrizia , Dean, James , Zhou, Huafeng, Nangalia, Jyoti , Ganly, Peter S. , Farber, Charles Michael , Zachée, Pierre , Scheid, Christof , Kiladjian, Jean‐Jacques , Vannucchi, Alessandro M. , Mead, Adam J. , Mesa, Ruben A. , Perkins, Andrew C

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7011-7011

10.1200/jco.2016.34.15_suppl.7011 Get It

E3311 trial of transoral surgery for oropharynx cancer: Implementation of a novel surgeon credentialing and quality assurance process.
Weinstein, Gregory S., Mehra, Ranee , García, Joaquín J. , Chung, Christine H. , Gillison, Maura L. , Ringash, Jolie , Méndez, Eduardo, Richmon, Jeremy D. , Magnuson, Scott, Smith, Russel B., Thomas, Giovana R. , Richmon, Jeremy D , Li, Shuli , Ferris, Robert L. , Holsinger, F. Christopher , Quon, Harry , Wagner, Lynne I. , Lewin, Jan S. , Ridge, John Andrew , Bell, R. Bryan , Burtness, Barbara

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 6054-6054

10.1200/jco.2016.34.15_suppl.6054 Get It

NETTER-1 phase III: Efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-DOTATATE.
Wolin, Edward M. , Chasen, Beth, Kulke, Matthew H. , Caplin, Martyn , Baum, Richard P. , Hobday, Timothy J. , Hendifar, Andrew , Öberg, Kjell E., Sierra, Maribel Lopera , Kwekkeboom, Dik J., Ruszniewski, Philippe, Krenning, Eric P. , Kunz, Pamela L. , Strosberg, Jonathan , Bushnell, David

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 4005-4005

10.1200/jco.2016.34.15_suppl.4005 Get It

First-in-human trial of microRNA cancer therapy with MRX34, a liposomal miR-34 mimic: Phase Ia expansion in patients with advanced solid tumors.
Beg, Muhammad Shaalan , Sachdev, Jasgit C. , Lim, Ho Yeong , Kim, Tae‐You, Becerra, Carlos, Bader, Andreas G. , Stoudemire, Jay, Smith, Susan, Kim, Sinil, Hong, David S. , Brenner, Andrew Jacob , Borad, Mitesh J. , Park, Keunchil , Smith, Susan, Kang, Yoon‐Koo

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS2597-TPS2597

10.1200/jco.2016.34.15_suppl.tps2597 Get It

A phase I/II study of TKM-080301, a PLK1-targeted RNAi in patients with adrenocortical cancer (ACC).
Demeure, Michael J. , Armaghany, Tannaz , Ejadi, Samuel, Ramanathan, Ramesh K., Elfiky, Aymen, Smith, David C. , Sekar, Shobana , Carpten, John D. , Fredlund, Paul, Niforos, Demi, Dye, Andrew, Gahir, Sarabjit, Semple, Sean C., Kowalski, Mark , Strosberg, Jonathan , Whitsett, Timothy G. , Liang, Winnie S.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 2547-2547

10.1200/jco.2016.34.15_suppl.2547 Get It